Clinical Trial Update: Gastroprotective Efficacy of Rebamipide in Patients With Atrial Fibrillation Treated With DOACs [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating the gastroprotective effects of rebamipide in patients with atrial fibrillation treated with direct oral anticoagulants has …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Rebamipide (rebamipide)

Snippet

Sponsor: Pirogov Russian National Research Medical University | Conditions: Atrial Fibrillation (AF) | Phase 4 | Status: COMPLETED